Does Lurbinectedin only last a few months?

Lurbinectedin (Lurbinectedin) can significantly extend patient survival in some cases, but its specific effects vary depending on the patient's condition, cancer type and individual differences. For some patients, rubicartin treatment may only prolong life for a few months, while for others, it may extend survival for much longer. Here are some important considerations regarding the survival-prolonging effects of rubicartin treatment:

1.Cancer types: Rubicatin is commonly used to treat recurrent small cell lung cancer (SCLC) and recurrent synovial sarcoma. These cancer types are often more aggressive subtypes, and patients often have shorter survival times. The use of rubicatin is intended to prolong survival and improve patients' quality of life.

2.Individual differences: The survival prolongation effect of patients varies depending on individual differences. Some patients may show a stronger therapeutic response to rubicatin and be able to achieve longer survival. However, other patients may respond poorly to treatment and experience shorter survival.

3.Treatment options: Rubicatin is often used in combination with other treatments or medications to increase the effectiveness of the treatment. The choice of treatment may affect the degree of survival improvement. Individualized treatment plans help optimize treatment results.

4.Disease stage: Rubicatin is typically used when cancer has returned or is in advanced stages, and early diagnosis is often associated with better treatment outcomes. Therefore, the patient's disease stage is also one of the factors that affects the prolongation of survival.

Rubicardin has not yet been launched in China, so it is not included in medical insurance. Patients cannot purchase it domestically and need to purchase Rubicatin through overseas channels. There is only the original drug Rubicatin in foreign countries, and the price is relatively expensive. In comparison, the original drug in Singapore is slightly cheaper, priced at more than 30,000, and there are other American versions of the original drug, priced at more than 90,000.